Thomas F. Jaki
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 198 publications
Adaptive versus fixed designs in confirmatory clinical trials: centering the choice on ethics.
Journal: Clinical trials (London, England)
Published: August 04, 2026
Adaptive versus fixed designs in confirmatory clinical trials: centering the choice on ethics.
Journal: Clinical trials (London, England)
Published: August 04, 2026
An evaluation of designs for Phase I/IIa dose-finding studies in Tuberculosis.
Journal: Statistical methods in medical research
Published: June 01, 2026
Joint time-to-event partial order continual reassessment method and Joint time-to-event Bayesian logistic regression model: Statistical designs for dual agent phase I/II dose finding studies with late-onset toxicity and activity outcomes.
Journal: Statistical methods in medical research
Published: December 05, 2025
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.
Journal: The Journal of antimicrobial chemotherapy
Published: November 19, 2025
A digital imagery-competing task intervention for stopping intrusive memories in trauma-exposed health-care staff during the COVID-19 pandemic in the UK: a Bayesian adaptive randomised clinical trial.
Journal: The lancet. Psychiatry
Published: November 13, 2025
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.
Journal: Clinical pharmacology and therapeutics
Published: October 08, 2025
A Fast, Flexible Simulation Framework for Bayesian Adaptive Designs-The R Package BATSS.
Journal: Pharmaceutical statistics
Published: October 06, 2025
Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease.
Journal: Transplantation and cellular therapy
Published: August 09, 2025
Seamless monotherapy-combination phase I dose-escalation model-based design.
Journal: Clinical trials (London, England)
Published: July 12, 2025
Using circulating tumor DNA as a novel biomarker of efficacy for dose-finding designs in oncology.
Journal: Statistical methods in medical research
Published: July 01, 2025
Last Updated: 09/26/2026